Statute Details
- Title: Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021
- Act Code: HSA2020-S1036-2021
- Type: Subsidiary Legislation (SL)
- Authorising Act: Healthcare Services Act 2020 (section 57)
- Commencement: 3 January 2022
- Current version reference: Current version as at 27 Mar 2026 (with amendments including S 417/2023 and S 842/2023)
- Primary subject matter: Licensing-related operational, safety, quality, personnel, reporting, record-keeping, and pricing transparency requirements for clinical laboratory services and radiological services
- Key structure: Part 1 (Preliminary) to Part 8 (Miscellaneous) + Schedule
- Notable provisions (from extract): Definitions (reg 2); application and specified services (regs 3–4); notification and prohibited delivery modes (regs 4A–4B); personnel governance (regs 5–10); quality and equipment (regs 11–13); safety (regs 14–16); laboratory-specific requirements (regs 17–25); radiology-specific requirements (regs 26–32B); reporting (regs 33–40); outsourcing and records (regs 41–45); price transparency and display of charges (regs 46–47); offence (reg 48)
What Is This Legislation About?
The Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021 (“the Regulations”) set out detailed, practical rules for how licensed providers must run clinical laboratory services and radiological services in Singapore. While the Healthcare Services Act 2020 establishes the licensing framework, these Regulations focus on the “how”: governance, quality systems, safety controls, specimen and image handling, reporting obligations, and record-keeping.
In plain language, the Regulations aim to ensure that diagnostic testing and imaging are performed reliably, safely, and with appropriate clinical oversight. They also require that results are communicated in a structured and accountable way, including urgent notification in emergencies and mechanisms to identify and review incidental or abnormal findings.
The scope is not limited to the technical act of testing or imaging. It extends to organisational arrangements (such as appointing a Clinical Governance Officer and section leaders), operational processes (quality management systems, specimen acceptance and rejection, image safeguards), and transparency (price disclosure and display of charges). For practitioners, the Regulations are therefore best understood as compliance requirements that must be embedded into day-to-day service delivery.
What Are the Key Provisions?
1. Definitions, application, and “specified services”
The Regulations begin with definitions (reg 2) that anchor key concepts such as “clinical laboratory service”, “radiological service”, “imaging modality”, “imaging service”, “laboratory discipline”, and “licensee”. These definitions matter because many obligations attach to whether an activity qualifies as an “applicable service” (a clinical laboratory service or radiological service). The Regulations also include provisions on application and on “specified services” (regs 3–4), which determine which services fall within the regulatory scheme.
2. Notification of certain imaging modalities and prohibited delivery modes
The Regulations include targeted controls for imaging services. Regulation 4A requires notification of certain imaging modalities. This is a compliance trigger: providers must identify whether their service includes modalities that require advance or ongoing notification to the relevant authority. Regulation 4B (as reflected in the extract) prohibits certain service delivery modes—particularly where service delivery is attempted through remote or otherwise restricted means. Practically, this means that even where technology could enable remote workflows, the Regulations restrict how and when such models can be used.
3. Personnel governance and competence
Part 2 is central to accountability. Regulations 5 and 6 set skills and competency requirements for the Clinical Governance Officer for clinical laboratory services and radiological services respectively. Regulation 7 adds duties and responsibilities of that officer, reinforcing that governance is not merely nominal. Regulations 8 and 9 require the licensee to appoint a “section leader” and set out the duties of that leader. Regulation 10 then provides general requirements relating to personnel, which typically include ensuring appropriate staffing, competence, and compliance culture.
4. Quality management system, equipment, and patient ordering
Part 3 requires a quality management system (reg 11) and sets standards for equipment and fittings (reg 12). Regulation 12A addresses additional requirements where applicable service is provided using approved conveyances or at temporary premises—important for mobile imaging units or temporary laboratory setups. Regulation 13 provides that services may be provided to patients only where ordered by a “requestor”. This is a clinical control: it prevents testing or imaging from being performed without an appropriate clinical order, supporting patient safety and appropriate utilisation.
5. Safety programme and protective measures
Part 4 focuses on safety. Regulation 14 requires a safety programme, and regulation 15 requires the licensee to ensure personnel comply with safety plans. Regulation 16 requires personal protective equipment to be provided. For radiological services, these provisions operate alongside radiation protection principles under the Radiation Protection Act 2007 and related regulations; however, the Regulations themselves impose service-level safety governance and PPE obligations that must be implemented regardless of the broader radiation framework.
6. Clinical laboratory service requirements: specimen handling and test validity
Part 5 sets out laboratory-specific operational requirements. Regulations 17–19 address instructions for specimen collection, acceptance and rejection of specimens, and handling and transport. These provisions are designed to prevent pre-analytical errors (wrong specimen type, improper collection, compromised transport) that can lead to inaccurate results. Regulations 20 and 21 require that tests must have clinical utility and must be accurate. This is a compliance standard that goes beyond technical performance: it requires that the test is appropriate for clinical decision-making and that accuracy is maintained.
Regulation 22 sets standards for reagents. Regulation 23 requires a chemical hygiene plan and facilities, which is particularly relevant for laboratories handling chemicals and hazardous materials. Regulation 23A addresses tests on radioactive specimens. Regulations 24 and 25 cover documentation relating to tests and quality control of tests, ensuring traceability and ongoing performance monitoring.
7. Radiological service requirements: facilities, qualifications, images, and special safeguards
Part 6 covers radiological services. Regulation 26 requires appropriate facilities and equipment. Regulation 27 requires required qualifications for conducting radiological examinations—again emphasising competence and accountability. Regulation 28 addresses handling of radiological images, which is critical for confidentiality, integrity, and clinical usability.
Regulation 29 provides general safeguards for radiological examinations. Regulations 30–31 impose specific safeguards where contrast agents are involved, and where anaesthesia or sedation is used. These provisions are particularly important for risk management: contrast and sedation introduce additional clinical hazards and require enhanced procedural safeguards. Regulation 32 addresses testing of specimen (relevant where radiological services interact with specimen-based processes). Regulations 32A and 32B address conduct of simple in vitro diagnostic tests and instructions for self-collection of specimens, indicating that the Regulations also contemplate patient-facing or remote-adjacent workflows—subject to the earlier restrictions on prohibited delivery modes.
8. Reporting of results: qualified persons, content, urgency, and error handling
Part 7 is a major compliance area for clinical governance and medicolegal risk. Regulation 33 identifies who is qualified to issue reports. Regulation 34 requires written reports to be issued. Regulation 35 sets out contents of reports, ensuring that reports are clinically meaningful and consistent. Regulation 36 requires urgent notification of results or findings in emergency—this is a time-critical duty that can affect patient outcomes and liability exposure.
Regulation 37 requires identification and review of incidental or abnormal findings, which is important because imaging may reveal unexpected findings requiring follow-up. Regulation 38 requires notification of error, and Regulations 39–40 require that copies of reports be complete and that processes exist to ensure prompt reporting. Together, these provisions create an auditable reporting workflow and reduce the risk of incomplete or delayed communication.
9. Outsourcing, records, tracing, and price transparency
Part 8 includes miscellaneous but highly practical obligations. Regulation 41 addresses outsourcing of tests or radiological examinations, which is crucial for laboratories that rely on third-party providers. Regulations 42–44 require records to be kept for each specimen, each test, and each radiological examination respectively. Regulation 44A requires tracing of records from report, strengthening end-to-end accountability (a practitioner should expect that a report must be traceable to the underlying data and processes). Regulation 45 requires keeping of other records.
Regulations 46 and 47 address price transparency and display of charges. These provisions are designed to support patient choice and informed decision-making. Finally, Regulation 48 creates an offence provision, signalling that breaches can lead to regulatory enforcement and penalties.
How Is This Legislation Structured?
The Regulations are organised into eight Parts plus a Schedule. Part 1 contains preliminary matters: citation and commencement, definitions, application, specified services, notification of certain imaging modalities, and prohibited service delivery modes. Part 2 sets personnel requirements, including the Clinical Governance Officer and section leader roles. Part 3 addresses processes, equipment, and fittings, including quality management systems and rules about patient ordering. Part 4 sets safety requirements, including safety programmes and PPE. Part 5 contains clinical laboratory-specific requirements (specimen and test controls). Part 6 contains radiological service-specific requirements (facilities, qualifications, image handling, and safeguards for contrast and sedation). Part 7 governs reporting of results, including urgent notification and error handling. Part 8 covers outsourcing, record-keeping, tracing, and price transparency, and ends with an offence provision. The Schedule supports key definitions and lists relevant modalities and laboratory disciplines.
Who Does This Legislation Apply To?
The Regulations apply to “licensees” who hold licences to provide clinical laboratory services and/or radiological services under the Healthcare Services Act 2020. In practice, this includes operators of laboratories and imaging centres, as well as any service providers delivering applicable services within Singapore’s regulatory framework.
The obligations apply not only to the corporate licensee but also to the operational structures the licensee must establish—such as appointing a Clinical Governance Officer and section leaders, ensuring personnel competence, implementing quality and safety systems, and maintaining records and reporting processes. Where outsourcing occurs, the licensee remains responsible for compliance and must manage third-party performance within the regulatory requirements.
Why Is This Legislation Important?
For practitioners, these Regulations are important because they translate licensing into concrete operational duties. Many disputes in healthcare regulation arise from failures in process—incorrect specimen handling, inadequate quality control, incomplete reporting, delayed urgent notifications, or poor traceability. The Regulations directly target these risk points through enforceable requirements.
From a compliance and enforcement perspective, the Regulations create a structured audit trail: documentation, quality control, records per specimen/test/examination, and tracing from report. This is particularly significant in medicolegal contexts, where the ability to demonstrate what was done, when, by whom, and using what controls can be decisive.
Finally, the Regulations’ inclusion of price transparency and display of charges reflects a broader policy shift: healthcare regulation is not only about clinical safety and quality, but also about patient-facing transparency and accountability. Practitioners advising healthcare providers should therefore treat these Regulations as both a clinical governance instrument and a commercial compliance framework.
Related Legislation
- Healthcare Services Act 2020 (Act 3 of 2020) — licensing framework and enabling powers
- Healthcare Services (General) Regulations 2021 (G.N. No. S 1035/2021) — general regulatory provisions (including definitions such as “business name”)
- Radiation Protection Act 2007 — overarching radiation protection regime relevant to radiological services
- Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023) — referenced for definitions (e.g., “collaborative prescribing practitioner”)
Source Documents
This article provides an overview of the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.